From Cancer Patient to Cancer Survivor: Lost in Transition
From Cancer Patient to Cancer Survivor: Lost in Transition Books
Product Description
With the risk of more than one in three getting cancer during a lifetime, each of us is likely to experience cancer, or know someone who has survived cancer. Although some cancer survivors recover with a renewed sense of life and purpose, what has often been ignored is the toll taken by cancer and its treatment – on health, functioning, sense of wellbeing, and well-being. Long lasting effects of treatment may be apparent shortly after its completion or arise years later. The transition from active treatment to post-treatment care is critical to long-term health. “From Cancer Patient to Cancer Survivor” focuses on survivors of adult cancer during the phase of care that follows primary treatment. The book raises awareness of the medical, functional, and psychosocial consequences of cancer and its treatment. It defines quality health care for cancer survivors and identifies strategies to achieve it. The book also recommends improvements in the quality of life of cancer survivors through policies that make sure their access to psychosocial services, honest employment practices, and health insurance. This book will be of particular interest to cancer patients and their advocates, health care providers and their leadership, health insurers, employers, research sponsors, and the broadcast and their elected representatives.
Buy Cheap From Cancer Patient to Cancer Survivor: Lost in Transition Online
Related posts:
- The Psychology of Survivor: Leading Psychologists Take an Unauthorized Look at the Most Elaborate Psychological Experiment Ever Conducted . . . Survivor!
- Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs
- The Man Who Lost Himself
- Treating The Adult Survivor Of Childhood Sexual Abuse: A Psychoanalytic Perspective
- The Nature of Health: How America Lost, and Can Regain, a Basic Human Value

This is an editted transcipt of a Symposium. For the interested audience, it is quite excellent and reviews the current issues relating to the transition from active treatment of a malignancy to survivorship and follow up. Not compulsory.
Rating: 4 / 5